Skip to content

Abbott ABT Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Boston Scientific logo
Boston ScientificBSX
DexCom logo
DexComDXCM
Edwards Lifesciences logo
Edwards LifesciencesEW
Merck & Co. logo
Merck & Co.MRK
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
ResMed logo
ResMedRMD

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.2%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$154.15B-22.5%
Enterprise value$181.39B-13.1%
P/E24.6×+9.8×
P/S3.4×-1.3×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's treasury stock, shares (in shares)?
Abbott (ABT) reported treasury stock, shares (in shares) of 256.4M in Q1 2026.
How has Abbott's treasury stock, shares (in shares) changed year-over-year?
Abbott's treasury stock, shares (in shares) increased by 0.2% year-over-year, from 256M to 256.4M.
What is the long-term trend for Abbott's treasury stock, shares (in shares)?
Over 4 years (2021 to 2025), Abbott's treasury stock, shares (in shares) has grown at a 4.1% compound annual growth rate (CAGR), from 221.2M to 260.2M.